Diabetic retinopathy is not curable. Treatments can slow or stop the disease from getting worse, and in some cases significantly improve vision, but they cannot fully reverse the underlying damage diabetes causes to retinal blood vessels. Because diabetes itself is a lifelong condition, the risk of further retinal damage persists even after successful treatment.
That said, the picture is more nuanced than a simple “no.” How early the disease is caught, how well blood sugar is controlled, and which treatments are used all shape whether you lose vision or keep it for decades. Understanding what’s actually happening in your eyes helps explain why a cure remains out of reach and what you can realistically expect.
What Happens Inside the Eye
Diabetic retinopathy progresses through two broad stages, and the type of damage at each stage is different.
In the earlier stage, called non-proliferative diabetic retinopathy, high blood sugar gradually weakens the tiny blood vessels in your retina. These damaged vessels develop small bulges (microaneurysms), leak blood and fluid, and eventually close off entirely. As more capillaries shut down, patches of the retina lose their blood supply. The body tries to compensate by rerouting blood through remaining vessels, which dilate abnormally under the extra load. This stage can progress slowly over years, and many people have no symptoms at all during it.
If enough of the retina becomes starved of oxygen, the disease crosses into the proliferative stage. Your eye attempts to grow new blood vessels to replace the ones that closed, but these new vessels are fragile and poorly formed. They grow along the surface of the retina and into the gel that fills the eye. When they rupture, they cause sudden bleeding inside the eye. They can also pull on the retina, creating scar tissue and potentially detaching the retina from the back of the eye. This is where serious, sometimes sudden vision loss happens.
Why It Can’t Be Fully Reversed
The core problem is structural. Once retinal capillaries close permanently and the nerve cells they supplied are damaged, that tissue doesn’t regenerate. Treatments target the consequences of the disease, not the root cause. They can stop new abnormal vessels from growing, reduce swelling, and seal leaking blood vessels, but they can’t rebuild the fine capillary network that was lost or restore dead retinal cells.
As the Mayo Clinic puts it directly: treatment can slow or stop the worsening of diabetic retinopathy, but it’s not a cure. Even after treatment, you’ll need regular eye exams, and additional treatment may be needed down the road.
Can Early-Stage Damage Improve?
There is some encouraging evidence here, with an important caveat. In clinical studies, patients who achieved tight blood sugar control early in their disease saw long-term benefits that persisted for years. In one study, intensive blood sugar management reduced the risk of developing retinopathy from 23.2% to 6.2%. Another trial found that patients who had undergone intensive glucose control had retinopathy progression rates of 5.8%, compared to 12.7% in those with standard control, and this benefit lasted even after blood sugar levels between the two groups became similar, up to eight years after the original treatment period.
In the STENO study, patients who experienced worsening eye changes after starting aggressive blood sugar treatment actually saw their retinal health improve by the two-year mark. So in early disease, bringing blood sugar under control can allow some mild changes like microaneurysms to stabilize or partially resolve.
The caveat: rapidly improving blood sugar can temporarily make retinopathy worse before it gets better. This “early worsening” phenomenon has been documented as early as three months and as late as three years after starting intensive glucose management. It typically involves new microaneurysms and small hemorrhages. Despite this initial setback, patients treated intensively consistently had better long-term outcomes than those on conventional treatment.
How Injections Protect Your Vision
The most common treatment for diabetic retinopathy today involves injections of medication directly into the eye. These drugs block a protein that drives abnormal blood vessel growth and leaking. The results are genuinely significant. In major clinical trials, patients receiving these injections gained between 8 and 13 letters on a standard eye chart over one to two years, while patients receiving only laser treatment stayed roughly the same or lost vision slightly.
For people starting with worse vision (around 20/50 to 20/320), the gains were even more dramatic, with improvements averaging 18 letters in some trials. To put that in perspective, 15 letters on an eye chart equals about three lines, enough to change whether you can read a menu or recognize a face across a room.
The treatment frequency is front-loaded. In one five-year study, patients received eight to nine injections in the first year, tapering to two or three in the second year, one or two in the third, and often none by the fourth or fifth year. Vision gains achieved early were maintained through this tapering period. The injections don’t cure the disease, but they can hold the line on your vision for years.
When Surgery Becomes Necessary
Laser treatment and surgery enter the picture primarily in proliferative disease. Laser photocoagulation burns small areas of the peripheral retina to reduce its oxygen demand, which slows the growth of abnormal blood vessels. It sacrifices some side vision to protect central vision.
When bleeding fills the eye or scar tissue pulls on the retina, a surgical procedure called vitrectomy may be needed. The surgeon removes the blood-filled gel from inside the eye and repairs any retinal detachment. In a seven-year study of patients with proliferative disease who underwent this surgery, average vision improved dramatically, from roughly 20/775 before surgery to 20/53 at the last follow-up (a median of 18 months later). Vision continued improving over two years post-surgery, reaching an average of 20/51 in patients followed that long.
These numbers show that even advanced disease doesn’t necessarily mean permanent blindness. Surgery can recover substantial vision, though it works best when performed before the retina detaches.
Early Detection Changes the Outcome
Because diabetic retinopathy often causes no symptoms until significant damage has occurred, screening is critical. AI-powered screening tools are increasingly available and can analyze retinal photographs with 90 to 95% sensitivity, meaning they catch the vast majority of cases. In some contexts, AI actually outperforms manual screening by human graders in detecting early disease, particularly when eye dilation isn’t used (90% sensitivity for AI versus 79% for manual review).
This matters because the disease is far easier to manage when caught early. At the non-proliferative stage, tight blood sugar and blood pressure control alone may be enough to keep it stable for years. Once it reaches the proliferative stage, you’re looking at injections, laser treatment, or surgery, all of which work but carry their own risks and burdens. Annual eye exams for anyone with diabetes remain the single most effective way to catch the disease when intervention can do the most good.
What “Manageable” Actually Looks Like
Living with diabetic retinopathy means committing to ongoing monitoring and, in many cases, periodic treatment. Blood sugar control is the foundation. Keeping your levels steady won’t undo existing damage, but it substantially reduces the odds of progression. The long-term data is striking: the protective effect of a period of intensive glucose management persists for up to 18 years, even after blood sugar control becomes less strict.
If you need eye injections, the first year is the most demanding, with monthly or near-monthly visits. After that, many people can shift to less frequent treatment while maintaining their vision gains. If you’ve had laser treatment or surgery, follow-up exams are essential because new abnormal vessels can develop over time.
The honest answer to “is it curable” is no, but the practical reality is that most people diagnosed early and treated consistently keep functional vision throughout their lives. The disease requires respect and attention, not resignation.